Try our Advanced Search for more refined results
February 07, 2020
Gilead Sciences, Inc. v. Apotex, Inc. et al
Case Number:
1:20-cv-00189
Court:
Nature of Suit:
Patent - Abbreviated New Drug Application(ANDA)
Judge:
Firms
- Abrams & Bayliss
- Cooley LLP
- Fish & Richardson
- Morris James
- Phillips McLaughlin
- Smith Katzenstein
- Young Conaway
Companies
Sectors & Industries:
View recent docket activity
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.
Coverage
-
September 12, 2022
Gilead Settles HIV Drugs Patent Suit On Eve Of Bench Trial
Gilead Sciences Inc. has settled its Delaware patent infringement lawsuit against five generic-drug makers on the eve of trial, inking a deal that calls for the delayed release until at least 2031 of generic alternatives to Gilead's line of medications that slow the progress of HIV infections.
Parties
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Direct access to case information and documents.
- All significant new filings across U.S. federal district courts, updated hourly on business days.
- Full-text searches on all patent complaints in federal courts.
- No-fee downloads of the complaints and so much more!
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login